Our unwavering commitment to health and compliance is reflected in our adherence to both the Therapeutic Goods Administration’s TGO-110 standards and the Therapeutic Goods (Medical Device Standard - Therapeutic Vaping Devices) Order (MDSO).

These frameworks govern the quality,
safety, and performance of therapeutic vaping goods and devices, underscoring
our dedication to delivering products that meet the expectations of healthcare
professionals.

We are committed to setting a new benchmark in the industry, contributing to a healthier future by offering therapeutic nicotine solutions that prioritise patient safety and public health outcomes.

Importantly, Bay Pharma is entirely independent and maintains no affiliations with the tobacco industry.

At Bay Pharma, we are more than suppliers. Our operations are guided by the principles of integrity, transparency, and continuous innovation. We are innovators, advocates, and partners in health. Through ethical practices and forward-thinking solutions, we aim to reshape the nicotine landscape and support healthcare professionals in delivering better outcomes for nicotine users Australia wide.